Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer

NCT06355037 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Triple-negative Breast Cancer

Interventions

DRUG: Quercetin
DRUG: Dasatinib
DRUG: Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum

Sponsor

Fudan University